Jacobson Pharma Corporation Limited (2633.HK)

HKD 1.28

(2.4%)

Operating Expenses Summary of Jacobson Pharma Corporation Limited

  • Jacobson Pharma Corporation Limited's latest annual operating expenses in 2023 was 287.34 Million HKD , down -22.35% from previous year.
  • Jacobson Pharma Corporation Limited's latest quarterly operating expenses in 2023 FY was 332.37 Million HKD , down -22.35% from previous quarter.
  • Jacobson Pharma Corporation Limited reported a annual operating expenses of 428.07 Million HKD in annual operating expenses 2022, up 7.65% from previous year.
  • Jacobson Pharma Corporation Limited reported a annual operating expenses of 397.63 Million HKD in annual operating expenses 2021, up 14.05% from previous year.
  • Jacobson Pharma Corporation Limited reported a quarterly operating expenses of 152.24 Million HKD for 2023 Q4, down 0.0% from previous quarter.
  • Jacobson Pharma Corporation Limited reported a quarterly operating expenses of 162.59 Million HKD for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Jacobson Pharma Corporation Limited (2023 - 2013)

Historical Annual Operating Expenses of Jacobson Pharma Corporation Limited (2023 - 2013)

Year Operating Expenses Operating Expenses Growth
2023 287.34 Million HKD -22.35%
2022 428.07 Million HKD 7.65%
2021 397.63 Million HKD 14.05%
2020 348.64 Million HKD -6.86%
2019 374.32 Million HKD 23.1%
2018 304.09 Million HKD -6.25%
2017 324.38 Million HKD 0.31%
2016 323.36 Million HKD 5.88%
2015 305.41 Million HKD 22.15%
2014 250.03 Million HKD -5.75%
2013 265.27 Million HKD 0.0%

Peer Operating Expenses Comparison of Jacobson Pharma Corporation Limited

Name Operating Expenses Operating Expenses Difference
Pak Fah Yeow International Limited 24.42 Million HKD -1076.503%
Grand Pharmaceutical Group Limited 3.86 Billion HKD 92.557%
Extrawell Pharmaceutical Holdings Limited 35.52 Million HKD -708.819%
Wai Yuen Tong Medicine Holdings Limited 353.93 Million HKD 18.813%
Qianhai Health Holdings Limited 17.1 Million HKD -1580.207%
Lee's Pharmaceutical Holdings Limited 590.99 Million HKD 51.379%
Essex Bio-Technology Limited 1.22 Billion HKD 76.619%
Tongfang Kontafarma Holdings Limited 503.46 Million HKD 42.925%
PuraPharm Corporation Limited 216.62 Million HKD -32.646%
SSY Group Limited 1.98 Billion HKD 85.493%
JBM (Healthcare) Limited 163.87 Million HKD -75.345%
China Resources Pharmaceutical Group Limited 29.35 Billion HKD 99.021%